These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 33369425)
1. Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1. Ferraro M; Moroni E; Ippoliti E; Rinaldi S; Sanchez-Martin C; Rasola A; Pavarino LF; Colombo G J Phys Chem B; 2021 Jan; 125(1):101-114. PubMed ID: 33369425 [TBL] [Abstract][Full Text] [Related]
2. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist. Pandey P; Roy KK; Doerksen RJ J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534 [TBL] [Abstract][Full Text] [Related]
3. Protein Allostery and Ligand Design: Computational Design Meets Experiments to Discover Novel Chemical Probes. Triveri A; Sanchez-Martin C; Torielli L; Serapian SA; Marchetti F; D'Acerno G; Pirota V; Castelli M; Moroni E; Ferraro M; Quadrelli P; Rasola A; Colombo G J Mol Biol; 2022 Sep; 434(17):167468. PubMed ID: 35101454 [TBL] [Abstract][Full Text] [Related]
4. Molecular Modeling Study of a Receptor-Orthosteric Ligand-Allosteric Modulator Signaling Complex. Jiang C; He X; Wang Y; Chen CJ; Othman Y; Hao Y; Yuan J; Xie XQ; Feng Z ACS Chem Neurosci; 2023 Feb; 14(3):418-434. PubMed ID: 36692197 [TBL] [Abstract][Full Text] [Related]
5. Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1. Sanchez-Martin C; Moroni E; Ferraro M; Laquatra C; Cannino G; Masgras I; Negro A; Quadrelli P; Rasola A; Colombo G Cell Rep; 2020 Apr; 31(3):107531. PubMed ID: 32320652 [TBL] [Abstract][Full Text] [Related]
6. Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs. Platania CBM; Bucolo C Methods Mol Biol; 2021; 2253():245-254. PubMed ID: 33315227 [TBL] [Abstract][Full Text] [Related]
7. Dynamics-based community analysis and perturbation response scanning of allosteric interaction networks in the TRAP1 chaperone structures dissect molecular linkage between conformational asymmetry and sequential ATP hydrolysis. Verkhivker GM Biochim Biophys Acta Proteins Proteom; 2018 Aug; 1866(8):899-912. PubMed ID: 29684503 [TBL] [Abstract][Full Text] [Related]
8. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity. Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013 [TBL] [Abstract][Full Text] [Related]
9. Detecting Functional Dynamics in Proteins with Comparative Perturbed-Ensembles Analysis. Yao XQ; Hamelberg D Acc Chem Res; 2019 Dec; 52(12):3455-3464. PubMed ID: 31793290 [TBL] [Abstract][Full Text] [Related]
10. Are the Apo Proteins Suitable for the Rational Discovery of Allosteric Drugs? An X; Lu S; Song K; Shen Q; Huang M; Yao X; Liu H; Zhang J J Chem Inf Model; 2019 Jan; 59(1):597-604. PubMed ID: 30525607 [TBL] [Abstract][Full Text] [Related]
11. Cross-talk between allosteric and orthosteric binding sites of γ-amino butyric acid type A receptors (GABA Payghan PV; Nath Roy S; Bhattacharyya D; Ghoshal N J Biomol Struct Dyn; 2019 Aug; 37(12):3065-3080. PubMed ID: 30608219 [TBL] [Abstract][Full Text] [Related]
12. Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator. Hui WQ; Cheng Q; Liu TY; Ouyang Q J Mol Model; 2016 Apr; 22(4):90. PubMed ID: 27021209 [TBL] [Abstract][Full Text] [Related]
14. Integrating Molecular Dynamics and Machine Learning Algorithms to Predict the Functional Profile of Kinase Ligands. Frasnetti E; Cucchi I; Pavoni S; Frigerio F; Cinquini F; Serapian SA; Pavarino LF; Colombo G J Chem Theory Comput; 2024 Oct; 20(20):9209-9229. PubMed ID: 39387368 [TBL] [Abstract][Full Text] [Related]
15. Dual Binding to Orthosteric and Allosteric Sites Enhances the Anticancer Activity of a TRAP1-Targeting Drug. Hu S; Ferraro M; Thomas AP; Chung JM; Yoon NG; Seol JH; Kim S; Kim HU; An MY; Ok H; Jung HS; Ryu JH; Colombo G; Kang BH J Med Chem; 2020 Mar; 63(6):2930-2940. PubMed ID: 32068404 [TBL] [Abstract][Full Text] [Related]
16. A Random Forest Model for Predicting Allosteric and Functional Sites on Proteins. Chen AS; Westwood NJ; Brear P; Rogers GW; Mavridis L; Mitchell JB Mol Inform; 2016 Apr; 35(3-4):125-35. PubMed ID: 27491922 [TBL] [Abstract][Full Text] [Related]
17. Virtual Screening and Molecular Dynamics Study of Potential Negative Allosteric Modulators of mGluR1 from Chinese Herbs. Jiang L; Zhang X; Chen X; He Y; Qiao L; Zhang Y; Li G; Xiang Y Molecules; 2015 Jul; 20(7):12769-86. PubMed ID: 26184151 [TBL] [Abstract][Full Text] [Related]
18. Studying the binding interactions of allosteric agonists and antagonists of the CXCR4 receptor. Planesas JM; Pérez-Nueno VI; Borrell JI; Teixidó J J Mol Graph Model; 2015 Jul; 60():1-14. PubMed ID: 26080355 [TBL] [Abstract][Full Text] [Related]
19. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs. Bartuzi D; Kaczor AA; Matosiuk D Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568 [TBL] [Abstract][Full Text] [Related]
20. Neural relational inference to learn long-range allosteric interactions in proteins from molecular dynamics simulations. Zhu J; Wang J; Han W; Xu D Nat Commun; 2022 Mar; 13(1):1661. PubMed ID: 35351887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]